The global Cancer (Tumor) Profiling market is projected to grow from US$ 10270 million in 2024 to US$ 19410 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period.

Cancer (Tumor) Profiling Market

Cancer(tumor) profiling is the technology oncologists use to determine if the pathways of a patient's tumor match up with available targeted treatments. Tumor profiling starts with obtaining a sample of tumor tissue. The tissue is usually collected through a core biopsy, but it can also be taken during surgery.

Market Analysis and Insights: Global Cancer (Tumor) Profiling Market

Surging cancer prevalence across the globe is one of the major factors contributing to the market growth. Cancer is the second leading cause of death worldwide. One in six deaths worldwide is due to cancer. In middle- and lower-class economies, 70% of deaths are due to cancer. This expands the growth scope of the market. Surging public-private funding of targeted research activities, emergence of cancer profiling relative to traditional methods of cancer diagnosis, increasing geriatric population base, and increasing product innovation and development due to technological advancements across the world will provide lucrative opportunities for market players. Estimated period 2022-2029. In addition, the surge in the number of strategic cooperations, rising Internet penetration, increasing number of hospitals and laboratories, increasing cases of lung cancer, prostate cancer, and acute leukemia, and increasing healthcare expenditure per capita will lead to further expansion of the market growth rate in the future.

Report Covers:

This report presents an overview of global market for Cancer (Tumor) Profiling market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cancer (Tumor) Profiling, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer (Tumor) Profiling, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer (Tumor) Profiling revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer (Tumor) Profiling market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer (Tumor) Profiling revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cancer (Tumor) Profiling Market Report

Report Metric	Details
Report Name	Cancer (Tumor) Profiling Market
Accounted market size in 2024	US$ 10270 million
Forecasted market size in 2030	US$ 19410 million
CAGR	11.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Immunoassay NGS Mass Spectrometry Others
Segment by Application	Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Qiagen, Neogenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics Corporation, Nanostring Technologies, Oxford Gene Technology, Ribomed Biotechnologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer (Tumor) Profiling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer (Tumor) Profiling companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer (Tumor) Profiling revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Cancer (Tumor) Profiling Market growing?

Ans: The Cancer (Tumor) Profiling Market witnessing a CAGR of 11.2 during the forecast period 2024-2030.

What is the Cancer (Tumor) Profiling Market size in 2030?

Ans: The Cancer (Tumor) Profiling Market size in 2030 will be US$ 19410 million.

Who are the main players in the Cancer (Tumor) Profiling Market report?

Ans: The main players in the Cancer (Tumor) Profiling Market are Illumina, Qiagen, Neogenomics Laboratories, HTG Molecular Diagnostics, Genomic Health, Caris Life Sciences, Helomics Corporation, Nanostring Technologies, Oxford Gene Technology, Ribomed Biotechnologies

What are the Application segmentation covered in the Cancer (Tumor) Profiling Market report?

Ans: The Applications covered in the Cancer (Tumor) Profiling Market report are Clinical, Research

What are the Type segmentation covered in the Cancer (Tumor) Profiling Market report?

Ans: The Types covered in the Cancer (Tumor) Profiling Market report are Immunoassay, NGS, Mass Spectrometry, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immunoassay

1.2.3 NGS

1.2.4 Mass Spectrometry

1.2.5 Others

1.3 Market by Application

1.3.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Clinical

1.3.3 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer (Tumor) Profiling Market Perspective (2019-2030)

2.2 Global Cancer (Tumor) Profiling Growth Trends by Region

2.2.1 Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer (Tumor) Profiling Historic Market Size by Region (2019-2024)

2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Region (2025-2030)

2.3 Cancer (Tumor) Profiling Market Dynamics

2.3.1 Cancer (Tumor) Profiling Industry Trends

2.3.2 Cancer (Tumor) Profiling Market Drivers

2.3.3 Cancer (Tumor) Profiling Market Challenges

2.3.4 Cancer (Tumor) Profiling Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Cancer (Tumor) Profiling by Players

3.1.1 Global Cancer (Tumor) Profiling Revenue by Players (2019-2024)

3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2019-2024)

3.2 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Cancer (Tumor) Profiling, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Cancer (Tumor) Profiling Market Concentration Ratio

3.4.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2023

3.5 Global Key Players of Cancer (Tumor) Profiling Head office and Area Served

3.6 Global Key Players of Cancer (Tumor) Profiling, Product and Application

3.7 Global Key Players of Cancer (Tumor) Profiling, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer (Tumor) Profiling Breakdown Data by Type

4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2019-2024)

4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2025-2030)

5 Cancer (Tumor) Profiling Breakdown Data by Application

5.1 Global Cancer (Tumor) Profiling Historic Market Size by Application (2019-2024)

5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer (Tumor) Profiling Market Size (2019-2030)

6.2 North America Cancer (Tumor) Profiling Market Size by Type

6.2.1 North America Cancer (Tumor) Profiling Market Size by Type (2019-2024)

6.2.2 North America Cancer (Tumor) Profiling Market Size by Type (2025-2030)

6.2.3 North America Cancer (Tumor) Profiling Market Share by Type (2019-2030)

6.3 North America Cancer (Tumor) Profiling Market Size by Application

6.3.1 North America Cancer (Tumor) Profiling Market Size by Application (2019-2024)

6.3.2 North America Cancer (Tumor) Profiling Market Size by Application (2025-2030)

6.3.3 North America Cancer (Tumor) Profiling Market Share by Application (2019-2030)

6.4 North America Cancer (Tumor) Profiling Market Size by Country

6.4.1 North America Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Cancer (Tumor) Profiling Market Size by Country (2019-2024)

6.4.3 North America Cancer (Tumor) Profiling Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Cancer (Tumor) Profiling Market Size (2019-2030)

7.2 Europe Cancer (Tumor) Profiling Market Size by Type

7.2.1 Europe Cancer (Tumor) Profiling Market Size by Type (2019-2024)

7.2.2 Europe Cancer (Tumor) Profiling Market Size by Type (2025-2030)

7.2.3 Europe Cancer (Tumor) Profiling Market Share by Type (2019-2030)

7.3 Europe Cancer (Tumor) Profiling Market Size by Application

7.3.1 Europe Cancer (Tumor) Profiling Market Size by Application (2019-2024)

7.3.2 Europe Cancer (Tumor) Profiling Market Size by Application (2025-2030)

7.3.3 Europe Cancer (Tumor) Profiling Market Share by Application (2019-2030)

7.4 Europe Cancer (Tumor) Profiling Market Size by Country

7.4.1 Europe Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Cancer (Tumor) Profiling Market Size by Country (2019-2024)

7.4.3 Europe Cancer (Tumor) Profiling Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Cancer (Tumor) Profiling Market Size (2019-2030)

8.2 China Cancer (Tumor) Profiling Market Size by Type

8.2.1 China Cancer (Tumor) Profiling Market Size by Type (2019-2024)

8.2.2 China Cancer (Tumor) Profiling Market Size by Type (2025-2030)

8.2.3 China Cancer (Tumor) Profiling Market Share by Type (2019-2030)

8.3 China Cancer (Tumor) Profiling Market Size by Application

8.3.1 China Cancer (Tumor) Profiling Market Size by Application (2019-2024)

8.3.2 China Cancer (Tumor) Profiling Market Size by Application (2025-2030)

8.3.3 China Cancer (Tumor) Profiling Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cancer (Tumor) Profiling Market Size (2019-2030)

9.2 Asia Cancer (Tumor) Profiling Market Size by Type

9.2.1 Asia Cancer (Tumor) Profiling Market Size by Type (2019-2024)

9.2.2 Asia Cancer (Tumor) Profiling Market Size by Type (2025-2030)

9.2.3 Asia Cancer (Tumor) Profiling Market Share by Type (2019-2030)

9.3 Asia Cancer (Tumor) Profiling Market Size by Application

9.3.1 Asia Cancer (Tumor) Profiling Market Size by Application (2019-2024)

9.3.2 Asia Cancer (Tumor) Profiling Market Size by Application (2025-2030)

9.3.3 Asia Cancer (Tumor) Profiling Market Share by Application (2019-2030)

9.4 Asia Cancer (Tumor) Profiling Market Size by Region

9.4.1 Asia Cancer (Tumor) Profiling Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Cancer (Tumor) Profiling Market Size by Region (2019-2024)

9.4.3 Asia Cancer (Tumor) Profiling Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type

10.2.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application

10.3.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country

10.4.1 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Cancer (Tumor) Profiling Introduction

11.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.1.5 Illumina Recent Developments

11.2 Qiagen

11.2.1 Qiagen Company Details

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Cancer (Tumor) Profiling Introduction

11.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.2.5 Qiagen Recent Developments

11.3 Neogenomics Laboratories

11.3.1 Neogenomics Laboratories Company Details

11.3.2 Neogenomics Laboratories Business Overview

11.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction

11.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.3.5 Neogenomics Laboratories Recent Developments

11.4 HTG Molecular Diagnostics

11.4.1 HTG Molecular Diagnostics Company Details

11.4.2 HTG Molecular Diagnostics Business Overview

11.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction

11.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.4.5 HTG Molecular Diagnostics Recent Developments

11.5 Genomic Health

11.5.1 Genomic Health Company Details

11.5.2 Genomic Health Business Overview

11.5.3 Genomic Health Cancer (Tumor) Profiling Introduction

11.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.5.5 Genomic Health Recent Developments

11.6 Caris Life Sciences

11.6.1 Caris Life Sciences Company Details

11.6.2 Caris Life Sciences Business Overview

11.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction

11.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.6.5 Caris Life Sciences Recent Developments

11.7 Helomics Corporation

11.7.1 Helomics Corporation Company Details

11.7.2 Helomics Corporation Business Overview

11.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction

11.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.7.5 Helomics Corporation Recent Developments

11.8 Nanostring Technologies

11.8.1 Nanostring Technologies Company Details

11.8.2 Nanostring Technologies Business Overview

11.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction

11.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.8.5 Nanostring Technologies Recent Developments

11.9 Oxford Gene Technology

11.9.1 Oxford Gene Technology Company Details

11.9.2 Oxford Gene Technology Business Overview

11.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction

11.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.9.5 Oxford Gene Technology Recent Developments

11.10 Ribomed Biotechnologies

11.10.1 Ribomed Biotechnologies Company Details

11.10.2 Ribomed Biotechnologies Business Overview

11.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction

11.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2019-2024)

11.10.5 Ribomed Biotechnologies Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Illumina Inc

Neogenomics Laboratories

Qiagen NV

HTG Molecular Diagnostics

Genomic Health

Caris Life Sciences

Helomics Corporation

Nanostring Technologies

Oxford Gene Technology

Ribomed Biotechnologies

List of Tables

Table 1. Global Cancer (Tumor) Profiling Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Immunoassay

Table 3. Key Players of NGS

Table 4. Key Players of Mass Spectrometry

Table 5. Key Players of Others

Table 6. Global Cancer (Tumor) Profiling Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Cancer (Tumor) Profiling Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Cancer (Tumor) Profiling Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Cancer (Tumor) Profiling Market Share by Region (2019-2024)

Table 10. Global Cancer (Tumor) Profiling Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Cancer (Tumor) Profiling Market Share by Region (2025-2030)

Table 12. Cancer (Tumor) Profiling Market Trends

Table 13. Cancer (Tumor) Profiling Market Drivers

Table 14. Cancer (Tumor) Profiling Market Challenges

Table 15. Cancer (Tumor) Profiling Market Restraints

Table 16. Global Cancer (Tumor) Profiling Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Cancer (Tumor) Profiling Revenue Share by Players (2019-2024)

Table 18. Global Top Cancer (Tumor) Profiling by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer (Tumor) Profiling as of 2023)

Table 19. Global Cancer (Tumor) Profiling Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Cancer (Tumor) Profiling Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Cancer (Tumor) Profiling, Headquarters and Area Served

Table 22. Global Key Players of Cancer (Tumor) Profiling, Product and Application

Table 23. Global Key Players of Cancer (Tumor) Profiling, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2019-2024)

Table 27. Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2025-2030)

Table 29. Global Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Cancer (Tumor) Profiling Revenue Share by Application (2019-2024)

Table 31. Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Cancer (Tumor) Profiling Revenue Share by Application (2025-2030)

Table 33. North America Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Cancer (Tumor) Profiling Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Cancer (Tumor) Profiling Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Cancer (Tumor) Profiling Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Cancer (Tumor) Profiling Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Cancer (Tumor) Profiling Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Cancer (Tumor) Profiling Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Cancer (Tumor) Profiling Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Cancer (Tumor) Profiling Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Cancer (Tumor) Profiling Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size by Country (2025-2030) & (US$ Million)

Table 65. Illumina Company Details

Table 66. Illumina Business Overview

Table 67. Illumina Cancer (Tumor) Profiling Product

Table 68. Illumina Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 69. Illumina Recent Developments

Table 70. Qiagen Company Details

Table 71. Qiagen Business Overview

Table 72. Qiagen Cancer (Tumor) Profiling Product

Table 73. Qiagen Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 74. Qiagen Recent Developments

Table 75. Neogenomics Laboratories Company Details

Table 76. Neogenomics Laboratories Business Overview

Table 77. Neogenomics Laboratories Cancer (Tumor) Profiling Product

Table 78. Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 79. Neogenomics Laboratories Recent Developments

Table 80. HTG Molecular Diagnostics Company Details

Table 81. HTG Molecular Diagnostics Business Overview

Table 82. HTG Molecular Diagnostics Cancer (Tumor) Profiling Product

Table 83. HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 84. HTG Molecular Diagnostics Recent Developments

Table 85. Genomic Health Company Details

Table 86. Genomic Health Business Overview

Table 87. Genomic Health Cancer (Tumor) Profiling Product

Table 88. Genomic Health Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 89. Genomic Health Recent Developments

Table 90. Caris Life Sciences Company Details

Table 91. Caris Life Sciences Business Overview

Table 92. Caris Life Sciences Cancer (Tumor) Profiling Product

Table 93. Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 94. Caris Life Sciences Recent Developments

Table 95. Helomics Corporation Company Details

Table 96. Helomics Corporation Business Overview

Table 97. Helomics Corporation Cancer (Tumor) Profiling Product

Table 98. Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 99. Helomics Corporation Recent Developments

Table 100. Nanostring Technologies Company Details

Table 101. Nanostring Technologies Business Overview

Table 102. Nanostring Technologies Cancer (Tumor) Profiling Product

Table 103. Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 104. Nanostring Technologies Recent Developments

Table 105. Oxford Gene Technology Company Details

Table 106. Oxford Gene Technology Business Overview

Table 107. Oxford Gene Technology Cancer (Tumor) Profiling Product

Table 108. Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 109. Oxford Gene Technology Recent Developments

Table 110. Ribomed Biotechnologies Company Details

Table 111. Ribomed Biotechnologies Business Overview

Table 112. Ribomed Biotechnologies Cancer (Tumor) Profiling Product

Table 113. Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2019-2024) & (US$ Million)

Table 114. Ribomed Biotechnologies Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer (Tumor) Profiling Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cancer (Tumor) Profiling Market Share by Type: 2023 VS 2030

Figure 3. Immunoassay Features

Figure 4. NGS Features

Figure 5. Mass Spectrometry Features

Figure 6. Others Features

Figure 7. Global Cancer (Tumor) Profiling Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Cancer (Tumor) Profiling Market Share by Application: 2023 VS 2030

Figure 9. Clinical Case Studies

Figure 10. Research Case Studies

Figure 11. Cancer (Tumor) Profiling Report Years Considered

Figure 12. Global Cancer (Tumor) Profiling Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cancer (Tumor) Profiling Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cancer (Tumor) Profiling Market Share by Region: 2023 VS 2030

Figure 15. Global Cancer (Tumor) Profiling Market Share by Players in 2023

Figure 16. Global Top Cancer (Tumor) Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer (Tumor) Profiling as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cancer (Tumor) Profiling Revenue in 2023

Figure 18. North America Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cancer (Tumor) Profiling Market Share by Type (2019-2030)

Figure 20. North America Cancer (Tumor) Profiling Market Share by Application (2019-2030)

Figure 21. North America Cancer (Tumor) Profiling Market Share by Country (2019-2030)

Figure 22. United States Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cancer (Tumor) Profiling Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Cancer (Tumor) Profiling Market Share by Type (2019-2030)

Figure 26. Europe Cancer (Tumor) Profiling Market Share by Application (2019-2030)

Figure 27. Europe Cancer (Tumor) Profiling Market Share by Country (2019-2030)

Figure 28. Germany Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Cancer (Tumor) Profiling Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Cancer (Tumor) Profiling Market Share by Type (2019-2030)

Figure 36. China Cancer (Tumor) Profiling Market Share by Application (2019-2030)

Figure 37. Asia Cancer (Tumor) Profiling Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Cancer (Tumor) Profiling Market Share by Type (2019-2030)

Figure 39. Asia Cancer (Tumor) Profiling Market Share by Application (2019-2030)

Figure 40. Asia Cancer (Tumor) Profiling Market Share by Region (2019-2030)

Figure 41. Japan Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Cancer (Tumor) Profiling Market Share by Country (2019-2030)

Figure 51. Brazil Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Cancer (Tumor) Profiling Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Illumina Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 58. Qiagen Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 59. Neogenomics Laboratories Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 60. HTG Molecular Diagnostics Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 61. Genomic Health Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 62. Caris Life Sciences Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 63. Helomics Corporation Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 64. Nanostring Technologies Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 65. Oxford Gene Technology Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 66. Ribomed Biotechnologies Revenue Growth Rate in Cancer (Tumor) Profiling Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions